1096 related articles for article (PubMed ID: 18852562)
1. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
2. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.
Goedert M
Arzneimittelforschung; 1995 Mar; 45(3A):403-9. PubMed ID: 7763334
[TBL] [Abstract][Full Text] [Related]
3. Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors.
Avila J; Wandosell F; Hernández F
Expert Rev Neurother; 2010 May; 10(5):703-10. PubMed ID: 20420491
[TBL] [Abstract][Full Text] [Related]
4. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
6. GSK-3 inhibitors for Alzheimer's disease.
Avila J; Hernández F
Expert Rev Neurother; 2007 Nov; 7(11):1527-33. PubMed ID: 17997701
[TBL] [Abstract][Full Text] [Related]
7. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Hardy J; Selkoe DJ
Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
[TBL] [Abstract][Full Text] [Related]
8. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
Brion JP
Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876
[TBL] [Abstract][Full Text] [Related]
9. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.
Wang JZ; Xia YY; Grundke-Iqbal I; Iqbal K
J Alzheimers Dis; 2013; 33 Suppl 1():S123-39. PubMed ID: 22710920
[TBL] [Abstract][Full Text] [Related]
10. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.
Zilka N; Filipcik P; Koson P; Fialova L; Skrabana R; Zilkova M; Rolkova G; Kontsekova E; Novak M
FEBS Lett; 2006 Jun; 580(15):3582-8. PubMed ID: 16753151
[TBL] [Abstract][Full Text] [Related]
11. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
12. The role of neurofibrillary tangles in Alzheimer disease.
Brion JP
Acta Neurol Belg; 1998 Jun; 98(2):165-74. PubMed ID: 9686275
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
Gómez-Ramos P; Morán MA
Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
[TBL] [Abstract][Full Text] [Related]
14. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
15. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
Savory J; Huang Y; Wills MR; Herman MM
Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957
[TBL] [Abstract][Full Text] [Related]
16. Role of protein kinase B in Alzheimer's neurofibrillary pathology.
Pei JJ; Khatoon S; An WL; Nordlinder M; Tanaka T; Braak H; Tsujio I; Takeda M; Alafuzoff I; Winblad B; Cowburn RF; Grundke-Iqbal I; Iqbal K
Acta Neuropathol; 2003 Apr; 105(4):381-92. PubMed ID: 12624792
[TBL] [Abstract][Full Text] [Related]
17. Transgenic zebrafish model of neurodegeneration.
Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
[TBL] [Abstract][Full Text] [Related]
18. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
[TBL] [Abstract][Full Text] [Related]
19. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ; Grundke-Iqbal I; Iqbal K
Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration.
Pei JJ; Braak H; Gong CX; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
Acta Neuropathol; 2002 Oct; 104(4):369-76. PubMed ID: 12200623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]